Suppr超能文献

大鼠尾动脉平滑肌α肾上腺素能受体的体外异质性

Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.

作者信息

Medgett I C, Langer S Z

出版信息

J Pharmacol Exp Ther. 1984 Jun;229(3):823-30.

PMID:6144792
Abstract

Vascular smooth muscle alpha adrenoceptors in the proximal end of the rat isolated tail artery have been classified by determining pA2 values and -log KB values for the antagonists prazosin, corynanthine and idazoxan (RX 781094, a new synthetic alpha-2 adrenoceptor antagonist) against norepinephrine. The effects of the antagonists on responses to intramural sympathetic nerve stimulation were also assessed. Artery segments were perfused and superfused with Krebs' solution containing cocaine (4 microM) and propranolol (1 microM). Maximum responses to KCl, norepinephrine and nerve stimulation were not significantly different from one another. Corynanthine (0.1-100 microM), prazosin (10 nM-1 microM) and idazoxan (1-100 microM) caused competitive antagonism of norepinephrine responses with pA2 values consistent with the presence of alpha-1 adrenoceptors. However, idazoxan (10-100 nM) also caused parallel shifts in the concentration-response curves to norepinephrine with -log KB values higher than those consistent with the presence of alpha-1 adrenoceptors. The results have been interpreted to suggest a predominance of smooth muscle alpha-1 adrenoceptors in addition to a subpopulation of smooth muscle alpha-2 adrenoceptors which also contribute to vasoconstrictor responses to norepinephrine. In contrast to the results obtained with exogenous norepinephrine, responses to electrical stimulation were exquisitely sensitive to blockade by prazosin but resistant to idazoxan , suggesting an involvement of an alpha-1 adrenoceptor in these responses. It is concluded that idazoxan may be used to distinguish alpha-1 and alpha-2 adrenoceptors on vascular smooth muscle in vitro and that the results favor the existence of alpha-1 and alpha-2 adrenoceptors in terms of the existing subclassification scheme for alpha adrenoceptor subtypes.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

通过测定拮抗剂哌唑嗪、育亨宾和咪唑克生(RX 781094,一种新型合成α-2肾上腺素能受体拮抗剂)针对去甲肾上腺素的pA2值和-log KB值,对大鼠离体尾动脉近端的血管平滑肌α肾上腺素能受体进行了分类。还评估了拮抗剂对壁内交感神经刺激反应的影响。动脉段用含有可卡因(4 microM)和普萘洛尔(1 microM)的 Krebs 溶液进行灌注和灌流。对氯化钾、去甲肾上腺素和神经刺激的最大反应彼此之间无显著差异。育亨宾(0.1 - 100 microM)、哌唑嗪(10 nM - 1 microM)和咪唑克生(1 - 100 microM)引起去甲肾上腺素反应的竞争性拮抗作用,其pA2值与α-1肾上腺素能受体的存在一致。然而,咪唑克生(10 - 100 nM)还导致去甲肾上腺素浓度 - 反应曲线平行移动,其-log KB值高于与α-1肾上腺素能受体存在一致的值。结果表明,除了平滑肌α-2肾上腺素能受体亚群外,平滑肌α-1肾上腺素能受体占主导地位,该亚群也参与对去甲肾上腺素的血管收缩反应。与外源性去甲肾上腺素获得的结果相反,对电刺激的反应对哌唑嗪的阻断极为敏感,但对咪唑克生有抗性,表明α-1肾上腺素能受体参与了这些反应。结论是,咪唑克生可用于在体外区分血管平滑肌上的α-1和α-2肾上腺素能受体,并且就现有的α肾上腺素能受体亚型分类方案而言,结果支持α-1和α-2肾上腺素能受体的存在。(摘要截断于250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验